Anticancer properties of bisaminoquinolines with modified linkers.


Journal

Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377

Informations de publication

Date de publication:
01 10 2021
Historique:
received: 05 05 2021
revised: 28 06 2021
accepted: 14 07 2021
pubmed: 24 7 2021
medline: 28 12 2021
entrez: 23 7 2021
Statut: ppublish

Résumé

We have previously reported the unique features of dimeric bisaminoquinolines as anticancer agents and have identified their cellular target as PPT1, a protein palmitoyl-thioesterase. We now report a systematic study on the role of the linker in these constructs, both with respect to the distance between the heterocycles, the linker hydrophobicity and the methylation status (primary vs. secondary vs. tertiary) of the central nitrogen atom on the observed biological activity.

Identifiants

pubmed: 34298133
pii: S0960-894X(21)00499-6
doi: 10.1016/j.bmcl.2021.128272
pmc: PMC8429239
mid: NIHMS1730730
pii:
doi:

Substances chimiques

Aminoquinolines 0
Antineoplastic Agents 0
Enzyme Inhibitors 0
Membrane Proteins 0
Thiolester Hydrolases EC 3.1.2.-
PPT1 protein, human EC 3.1.2.22

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

128272

Subventions

Organisme : NCI NIH HHS
ID : P01 CA114046
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016520
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Références

Eur J Med Chem. 2010 Feb;45(2):705-9
pubmed: 19945197
J Med Chem. 1998 Oct 22;41(22):4360-4
pubmed: 9784111
Autophagy. 2016;12(1):1-222
pubmed: 26799652
J Med Chem. 2001 May 24;44(11):1658-65
pubmed: 11356101
Eur J Med Chem. 2012 Jun;52:230-41
pubmed: 22483965
Autophagy. 2017 Apr 3;13(4):765-766
pubmed: 28118053
Clin Cancer Res. 2011 May 15;17(10):3478-89
pubmed: 21325076
Cancer Discov. 2019 Sep;9(9):1167-1181
pubmed: 31434711
Cancer Discov. 2017 Nov;7(11):1266-1283
pubmed: 28899863
Biochem Biophys Res Commun. 2003 Oct 10;310(1):84-93
pubmed: 14511652
Eur J Med Chem. 2012 Sep;55:335-45
pubmed: 22889556
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8253-8
pubmed: 22566612
Cancer Discov. 2019 Feb;9(2):220-229
pubmed: 30442709
Nat Rev Drug Discov. 2007 Nov;6(11):881-90
pubmed: 17971784

Auteurs

Yuanhao Wang (Y)

Department of Chemistry, University of Pennsylvania, United States.

Vaibhav Jain (V)

Department of Medicine and Abramson Cancer Center, University of Pennsylvania, United States.

Amanda Versace (A)

Department of Medicine and Abramson Cancer Center, University of Pennsylvania, United States.

Monika Bhardwaj (M)

Department of Medicine and Abramson Cancer Center, University of Pennsylvania, United States.

Mary Ann S Crissey (MAS)

Department of Medicine and Abramson Cancer Center, University of Pennsylvania, United States.

Ravi K Amaravadi (RK)

Department of Medicine and Abramson Cancer Center, University of Pennsylvania, United States. Electronic address: ravi.amaravadi@pennmedicine.upenn.edu.

Jeffrey D Winkler (JD)

Department of Chemistry, University of Pennsylvania, United States. Electronic address: winkler@sas.upenn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH